Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol

被引:7
作者
Briers, Pieter-Jan [1 ]
Langlois, Michel R. [1 ,2 ]
机构
[1] AZ St Jan Hosp, Dept Lab Med, Brugge, Belgium
[2] Univ Ghent, Dept Diagnost Sci, Fac Med & Hlth Sci, Ghent, Belgium
关键词
apolipoprotein B; LDL-cholesterol; Friedewald formula; Martin-Hopkins formula; Sampson formula; ATHEROGENIC LIPOPROTEINS; LOWERING THERAPY; DYSLIPIDEMIA; ASSOCIATION; EQUATION;
D O I
10.11613/BM.2022.010704
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: Two new formulas, the Martin-Hopkins and the Sampson formula, were recently developed to overcome shortcomings of the Friedewald formula for calculating LDL-cholesterol. We aimed to compare the concordance of the two formulas with apolipoprotein B (apoB), a surrogate marker of the number of LDL particles. Materials and methods: In a study of serum lipid data of 1179 patients who consulted the AZ St-Jan Hospital Bruges for cardiovascular risk assessment, the correlation and concordance of the Friedewald, Martin-Hopkins and Sampson formulas with apoB concentration, measured by immuno-nephelometry, were determined and compared. Results: The Martin-Hopkins formula showed significantly higher correlation coefficient than the Friedewald formula with apoB in the entire dataset and in patients with low LDL-cholesterol < 1.8 mmol/L. Both Martin-Hopkins and Sampson formulas yielded > 70% concordance of LDL-cholesterol with regard to treatment group classification based on population-equivalent thresholds of apoB in hypertriglyceridemic patients (2-4.5 mmol/L), with the highest concordance (75.6%) obtained using Martin-Hopkins formula vs. 60.5% with Friedewald formula. Conclusion: The Martin-Hopkins (and, to a lesser extent, Sampson) formula is more closely associated with the number of LDL particles than Friedewald formula. This, in combination with literature evidence of lesser accuracy of the Friedewald formula, is an argument to switch from Friedewald to a modified, improved formula.
引用
收藏
页数:11
相关论文
共 30 条
  • [11] From biomarkers to medical tests: The changing landscape of test evaluation
    Horvath, Andrea R.
    Lord, Sarah J.
    StJohn, Andrew
    Sandberg, Sverre
    Cobbaert, Christa M.
    Lorenz, Stefan
    Monaghan, Phillip J.
    Verhagen-Kamerbeek, Wilma D. J.
    Ebert, Christoph
    Bossuyt, Patrick M. M.
    [J]. CLINICA CHIMICA ACTA, 2014, 427 : 49 - 57
  • [12] New Sampson Low-Density Lipoprotein Equation: Better Than Friedewald and Martin-Hopkins
    Koch, Christopher D.
    El-Khoury, Joe M.
    [J]. CLINICAL CHEMISTRY, 2020, 66 (08) : 1120 - 1121
  • [13] Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
    Langlois, Michel R.
    Sniderman, Allan D.
    [J]. CURRENT CARDIOLOGY REPORTS, 2020, 22 (08)
  • [14] Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
    Langlois, Michel R.
    Nordestgaard, Borge G.
    Langsted, Anne
    Chapman, M. John
    Aakre, Kristin M.
    Baum, Hannsjoerg
    Boren, Jan
    Bruckert, Eric
    Catapano, Alberico
    Cobbaert, Christa
    Collinson, Paul
    Descamps, Olivier S.
    Duff, Christopher J.
    von Eckardstein, Arnold
    Hammerer-Lercher, Angelika
    Kamstrup, Pia R.
    Kolovou, Genovefa
    Kronenberg, Florian
    Mora, Samia
    Pulkki, Kari
    Remaley, Alan T.
    Rifai, Nader
    Ros, Emilio
    Stankovic, Sanja
    Stavljenic-Rukavina, Ana
    Sypniewska, Grazyna
    Watts, Gerald F.
    Wiklund, Olov
    Laitinen, Paivi
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (04) : 496 - 517
  • [15] Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
    Langlois, Michel R.
    Chapman, M. John
    Cobbaert, Christa
    Mora, Samia
    Remaley, Alan T.
    Ros, Emilio
    Watts, Gerald F.
    Boren, Jan
    Baum, Hannsjoerg
    Bruckert, Eric
    Catapano, Alberico
    Descamps, Olivier S.
    von Eckardstein, Arnold
    Kamstrup, Pia R.
    Kolovou, Genovefa
    Kronenberg, Florian
    Langsted, Anne
    Pulkki, Kari
    Rifai, Nader
    Sypniewska, Grazyna
    Wiklund, Olov
    Nordestgaard, Borge G.
    [J]. CLINICAL CHEMISTRY, 2018, 64 (07) : 1006 - 1033
  • [16] Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]
  • [17] Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation Insights From the FOURIER Trial
    Martin, Seth S.
    Giugliano, Robert P.
    Murphy, Sabina A.
    Wasserman, Scott M.
    Stein, Evan A.
    Ceska, Richard
    Lopez-Miranda, Jose
    Georgiev, Borislav
    Lorenzatti, Alberto J.
    Tikkanen, Matti J.
    Sever, Peter S.
    Keech, Anthony C.
    Pedersen, Terje R.
    Sabatine, Marc S.
    [J]. JAMA CARDIOLOGY, 2018, 3 (08) : 749 - 753
  • [18] Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
    Martin, Seth S.
    Blaha, Michael J.
    Elshazly, Mohamed B.
    Toth, Peter P.
    Kwiterovich, Peter O.
    Blumenthal, Roger S.
    Jones, Steven R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (19): : 2061 - 2068
  • [19] Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
    Martin, Seth S.
    Blaha, Michael J.
    Elshazly, Mohamed B.
    Brinton, Eliot A.
    Toth, Peter P.
    McEvoy, John W.
    Joshi, Parag H.
    Kulkarni, Krishnaji R.
    Mize, Patrick D.
    Kwiterovich, Peter O.
    DeFilippis, Andrew P.
    Blumenthal, Roger S.
    Jones, Steven R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (08) : 732 - 739
  • [20] Comparison of equations for the calculation of LDL-cholesterol in hospitalized patients
    Martins, J.
    Olorunju, S. A. S.
    Murray, L. M.
    Pillay, T. S.
    [J]. CLINICA CHIMICA ACTA, 2015, 444 : 137 - 142